Skip to main content

Conditions of publication

Agree to conditions of submission, BioMed Central's copyright and license agreement and article-processing charge (APC)

Copyright and license agreement

During submission, you will need to accept and confirm the following conditions:

  • All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria
  • That the article is original, has not already been published in a journal, and is not currently under consideration by another journal
  • That you agree to the terms of the BioMed Central Copyright and License Agreement, which we strongly recommend you read and, where applicable, Open Data policy. For authors who are prevented from being the copyright holder (for instance where Crown Copyright applies or researchers are US government employees), BioMed Central can accommodate non-standard copyright lines. If this applies to you, please contact us and provide details of your situation.

For more information see our Copyright and license policy.

Article-processing charge
An article-processing charge (APC) applies for each article accepted for publication in Genome Medicine . For further details please see our article-processing-charge page.

  • Editorial Board
  • Editorial Team
  • Sign up for article alerts and news from this journal
  • Contact us
  • Announcements

    C19 Rapid Review Initiative

    Genome Medicine has joined the C19 Rapid Review Initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.